Achillion to Present at the 2013 Leerink Swann Global Healthcare Conference

Achillion to Present at the 2013 Leerink Swann Global Healthcare Conference

NEW HAVEN, Conn., Feb. 8, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals,
Inc. (Nasdaq:ACHN) announced today that Michael Kishbauch, President and Chief
Executive Officer of Achillion, will present a corporate update at the Leerink
Swann Global Healthcare Conference on Wednesday, February 13, 2013 at 3:30
p.m. EST at the Waldorf-Astoria Hotel in New York, NY.

The live audio and video broadcast and the subsequent archived webcasts of the
Company's presentations will be available on the Company's website,
http://www.achillion.com, under the "News Center" section. The audio recording
will be archived for 30 days following the live presentation. Please connect
to Achillion's website several minutes prior to the start of the presentation
to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing
important new treatments to patients with infectious disease. Achillion's
proven discovery and development teams have advanced multiple product
candidates with novel mechanisms of action. Achillion is focused on solutions
for the most challenging problems in infectious disease including the
hepatitis C virus (HCV) and resistant bacterial infections. For more
information on Achillion Pharmaceuticals, please visit www.achillion.com or
call 1-203-624-7000.

CONTACT: Company Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 752-5510
         gschulman@achillion.com
        
         Investors:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com
 
Press spacebar to pause and continue. Press esc to stop.